Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Rendon A, Schäkel K (2023) Psoriasis Pathogenesis and Treatment. Int J Mol Sci 2019 Mar 20(6):1475
2. Benson JM, Peritt D, Scallon BJ, Heavner GA, Shealy DJ, Giles-Komar JM, Mascelli MA (2011 Nov-Dec) Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders. MAbs 3(6):535–545
3. Penmetsa GK, Sapra A, Morphea (2023) Aug 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 32644436
4. Cirone K, Vender R (2023) Plaque psoriasis and morphea in a patient on ustekinumab: a case report. SAGE Open Med Case Rep 11:2050313X231164207
5. Dogra S, Mahajan R, Psoriasis Epidemiology, clinical features, co-morbidities, and clinical scoring. Indian Dermatol Online J 2016 Nov-Dec ;7(6):471–480